[Value of hormone therapy in metastasizing breast cancer].
Increasing knowledge in pathophysiology of hormone-related malignant tumors of breast combined with successful development and application of endocrine-active drugs makes hormone-therapy more important in treatment of metastatic breast cancer. Basic connections, indications and clinical relevant treatments are briefly demonstrated.
D000616:Aminoglutethimide / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D009362:Neoplasm Metastasis; D010052:Ovariectomy; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D000616:Aminoglutethimide; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Stellenwert der Hormontherapie beim metastasierenden Mammakarzinom.